Parity and risk of death from lung cancer among a cohort of premenopausal parous women in Taiwan

Journal of Epidemiology

Volumn 22, Issue 4, 2012, Pages 364-369

  Cheng, Meng Hsuan ^a,b,c   Tsai, Shang Shyue ^d   Chen, Chih Cheng ^e   Ho, Shu Chen ^b   Chiu, Hui Fen ^f   Wu, Trong Neng ^g,h   Yang, Chun Yuh ^b,h  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Pingtung Hospital   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

^h NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cohort study; Lung cancer; Mortality; Parity

Indexed keywords

ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MIDDLE AGED; MORTALITY; PARITY; PREGNANCY; PREMENOPAUSE; RISK ASSESSMENT; TAIWAN;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PARITY; PREGNANCY; PREMENOPAUSE; RISK ASSESSMENT; TAIWAN; YOUNG ADULT;

EID: 84867157391     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20110123     Document Type: Article

References (46)

1. Department of Health, Taiwan. Statistics of causes of death. Taipei: Department of Health; 2011.
2. Ernster VL. Female lung cancer. Annu Rev Public Health. 1996;17:97-114.
3. Chen KY, Hsiao CF, Chang GC, Tsai YH, Su WC, Perng RP, et al. Hormone replacement therapy and lung cancer risk in Chinese. Cancer. 2007;110(8):1768-75.
4. Cheng TY, Wen CP, Tsai MC, Tsai SP. The current status of smoking behavior in Taiwan: data analysis from national health interview survey in 2001. Taiwan J Public Health. 2003;22:453-64.
5. Yang CY, Cheng BH, Hsu TY, Tsai SS, Hung CF, Wu TN. Female lung cancer mortality and sex ratios at birth near a peteroleum refinery plant. Environ Res. 2000;83:33-40.
6. Liu CC, Tsai SS, Chiu HF, Wu TN, Yang CY. Ambient exposure to criteria air pollutants and female lung cancer in Taiwan. Inhal Toxicol. 2008;20:311-7.
7. Brownson RC, Alavanja MC, Caporaso N, Simoes EJ, Chang JC. Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev. 1998;20:218-36.
8. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol. 2007;25:561-70.
9. Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 1999;59:3317-20.
10. Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol. 1993;138:281-93.
11. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996;88:183-92.
12. Siegfried JM. Women and lung cancer: does estrogen play a role? Lancet Oncol. 2001;2:506-13.
13. Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol. 2002;188(1-2):125-40.
14. Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002;62:2141-50.
15. Yen SS. Endocrinology of pregnancy. In: Creasy RK, Resnik R, editors. Maternal-Fetal Medicine: Principles and practice. 3rd ed. Philadelphia, PA: Saunders; 1994. p. 382-412.
16. Baik CS, Strauss GM, Speizer FE, Feskanich D. Reproductive factors, hormone use, and risk for lung cancer risk in postmenopausal women, the nurses' health study. Cancer Epidemiol Biomarkers Prev. 2010;19:2525-33.
17. Meinhold CL, Berrington de González A, Bowman ED, Brenner AV, Jones RT, Lacey JV Jr, et al. Reproductive and hormonal factors and the risk of nonsmall cell lung cancer. Int J Cancer. 2011;128:1404-13.
18. Paulus JK, Asomaning K, Kraft P, Johnson BE, Lin X, Christiani DC. Parity and risk of lung cancer in women. Am J Epidemiol. 2010;171:557-63.
19. Seow A, Poh WT, Teh M, Eng P, Wang YT, Tan WC, et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: Evidence for a protective effect of soy in nonsmokers. Int J Cancer. 2002;97:365-71.
20. Seow A, Koh WP, Wang R, Lee HP, Yu MC. Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese health study. Cancer Epidemiol Biomarkers Prev. 2009;18:821-7.
21. Weiss JM, Lacey JV Jr, Shu XO, Ji BT, Hou L, Yang G, et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol. 2008;168:1319-25.
22. Zatloukal P, Kubík A, Pauk N, Tomásek L, Petruzelka L. Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer. 2003;41:283-93.
23. Brinton LA, Gierach GL, Andaya A, Park Y, Schatzkin A, Hollenbeck AR, et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP diet and healthy study cohort. Cancer Epidemiol Biomarkers Prev. 2011;20:900-11.
24. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE. Hormonal factors and risk of lung cancer among women? Int J Epidemiol. 2003;32:263-71.
25. Liu Y, Inoue M, Sobue T, Tsugane S. Reproductive factors, hormonal use and the risk of lung cancer among middle-aged never-smoking Japanese women: A large-scale population-based study. Int J Cancer. 2005;117:662-6.
26. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer. 2007;120:2214-20.
27. Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol. 2007;25:5785-92.
28. Yang CY, Kuo HW, Chiu HF. Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer. Int J Gynecol Cancer. 2007; 17:32-6.
29. Chang CC, Chiu HF, Yang CY. Parity, age at first birth, and risk of death from pancreatic cancer: Evidence from a cohort in Taiwan. Pancreas. 2010;39:567-71.
30. Wu CH, Chan TF, Changchien CC, Yang CY. Parity, age at first birth, and risk of death from liver cancer: Evidence from a cohort in Taiwan. J Gastroenterol Hepatol. 2011;26:334-9.
31. Wu SC, Young CL. Study of the birth reporting system. J Natl Public Health Assoc. 1986;6:15-27.
32. Bahmanyar S, Lambe M, Zendehdel K, Nyrén O, Boffetta P, Ye W. Parity and risk of stomach cancer by sub-site: a national Swedish study. Br J Cancer. 2008;98:1295-300.
33. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998.
34. Stabile LP, Siegfried JM. Estrogen receptor pathways in lung cancer. Curr Oncol Rep. 2004;6:259-67.
35. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996;36:203-32.
36. Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids. 2005;70:372-81.
37. Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, et al. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control. 1995;6:217-24.
38. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996;87:6-12.
39. Mahabir S, Spitz MR, Barrera SL, Dong YQ, Eastham C, Forman MR. Dietary boron and hormone replacement therapy as risk factors for lung cancer. Am J Epidemiol. 2008;167: 1070-80.
40. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004;10:113-23.
41. Chie WC, Li CY, Huang CS, Chang KJ, Yen ML, Lin RS. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int J Cancer. 1998;77:219-23.
42. Yen ML, Yen BL, Bai CH, Lin RS. Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population. Gynecol Oncol. 2003;89:318-24.
43. Environmental Protection Agency (EPA), United States. Respiratory health effects of passive smoking: lung cancer and other disorders. Washington D.C.: EPA; 1992.
44. Lubin JH, Liang Z, Hrubec Z, Pershagen G, Schoenberg JB, Blot WJ, et al. Radon exposure in residences and lung cancer among women: combined analysis of three studies. Cancer Causes Control. 1994;5:114-28.
45. Ko YC, Lee CH, Chen MJ, Huang CC, Chang WY, Lin HJ, et al. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol. 1997;26:24-31.
46. Lu TH, Lee MC, Chou MC. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol. 2000;29:336-43.